PolyPid (PYPD) Income from Continuing Operations (2019 - 2026)
PolyPid (PYPD) posted Income from Continuing Operations of $7.84 million for Q2 2026, down 20.5% from $9.87 million a year earlier but up 1.5% from the prior quarter.
Powered by 
Analysis
PolyPid (PYPD) Income from Continuing Operations (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Continuing Operations at PolyPid was $31.61 million, down 7.9% year-over-year; for FY2025, it came in at $34.16 million, up 18.0% from FY2024.
- Annual Income from Continuing Operations shows a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- In prior years, PolyPid's Income from Continuing Operations was $28.94 million in FY2024 (+22.0%), $23.73 million in FY2023 (-39.6%), $39.3 million in FY2022 (-7.8%) and $42.6 million in FY2021 (+15.5%).
- Quarterly Income from Continuing Operations has run from a low of $5.55 million in Q3 2023 to a high of $13.5 million in Q4 2021 over five years.
- On a year-over-year basis, Income from Continuing Operations increased in five of the last eight quarters, with growth averaging 16.1%.
- The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q4 2021, with growth of 71.2%; the weakest was Q4 2022, with a decline of 52.2%.
- According to Business Quant data, Income from Continuing Operations for the three prior quarters was $7.73 million (Q1 2026), $8.64 million (Q4 2025) and $7.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | PolyPid | 95.94 Mn | 46.74 Mn | - | 7.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.84 Mn |
| Mar 31, 2026 | 7.73 Mn |
| Dec 31, 2025 | 8.64 Mn |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 9.87 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 8.49 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 6.29 Mn |
| Mar 31, 2024 | 6.43 Mn |
| Dec 31, 2023 | 6.34 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 5.82 Mn |
| Mar 31, 2023 | 6.02 Mn |
| Dec 31, 2022 | 6.46 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Jun 30, 2022 | 11.85 Mn |
| Mar 31, 2022 | 11.87 Mn |
| Dec 31, 2021 | 13.50 Mn |
| Sep 30, 2021 | 9.94 Mn |
API Access
PolyPid Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PYPD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "PYPD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PYPD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();